A recent study suggests a potential link between Ozempic (semaglutide) use and non-arteritic anterior ischemic optic neuropathy (NAION), a rare condition that can cause sudden, permanent vision loss
Second, it is given SC, IM or orally weekly injections or daily capsules, titrated to serum cobalamin but not intravenously
This allows the full dose to disperse into the tissue and prevents leakage
These drugs bind to the GLP-1 receptor and: Lower blood sugar by increasing insulin and reducing glucagon Slow gastric emptying Reduce appetite and food cravings Support clinically significant weight loss in many people They are commonly prescribed for: Type 2 diabetes Obesity or overweight with weight-related health risks Trials suggest GLP-1 agonists can reduce body weight by around 5 to 18 per cent on average, often with improvements in blood pressure, cholesterol and other cardiometabolic markers
Diabetes Obes Metab 10(7):545555 Chaudhury A, Duvoor C, Reddy Dendi VS, Kraleti S, Chada A, Ravilla R et al (2017) Clinical review of antidiabetic drugs: implications for type 2 diabetes mellitus management